Clinical Trials Logo

Hyperopia clinical trials

View clinical trials related to Hyperopia.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06098339 Active, not recruiting - Myopia Clinical Trials

Performance Evaluation of Reusable Contact Lenses When Worn For One Month By Habitual Soft Contact Lens Wearers

Start date: November 13, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the clinical performance of two different monthly replacement lens in habitual spherical soft lens wearers.

NCT ID: NCT05689567 Active, not recruiting - Myopia Clinical Trials

Focus-out Glasses on Emmetropization in Chinese Children

Start date: March 23, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to characterize the effects of peripheral focous-out glasses on emmetropization in non-myopic Chinese Children Aged 6-8 Years.This is a prospective, parallel-controlled randomized trial.

NCT ID: NCT04692012 Active, not recruiting - Myopia Clinical Trials

Treatment of Residual Hypermetropic Refraction on Pseudophakic Patients Using Allogenic Fresh Myopic Lenticule

ReLex-Smile
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The residual hypermetropic refraction on pseudophakic(Trifocal IOL) patients is difficult to treat surgically. In addition, there are not many suitable options to offer such patients presenting with this condition. Two current common surgeries to treat residual hyperopic refraction are refractive lens exchange (RLE) and excimer laser ablation (LASIK or PRK). Laser procedures: Photorefractive keratectomy (PRK); Laser assisted in situ keratomileusis (LASIK); Risks of LASIK include abnormalities of the corneal flap, epithelial ingrowth, corneal ectasia, refractive surprises, irregular astigmatism, decentration, visual aberrations, a loss of BCVA, infectious keratitis, symptoms, and diffuse lamellar keratitis. Refractive lens exchange (RLE); The risks of RLE are similar to those of cataract surgery and include endophthalmitis, a loss of accommodation, vitreous loss with posterior capsular rupture, and retinal detachment. The method used at the EYE Hospital Pristina using fresh lenticule implantation by ReLex-SMILE is safe and effective method, since there is no flap this prevents invasive damage to the anterior surface of the cornea contrary to the LASIK where flap is present posing risk for epithelial ingrowth. Before SMILE,YAG-laser capsulotomy should be performed on all patients, regardless of posterior capsule ossification, in pseudophakic patients with residual refraction. When the YAG-laser is applied after the SMILE,there will be a diopter change.

NCT ID: NCT04616144 Active, not recruiting - Hyperopia Clinical Trials

Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

The refractive combination of high hyperopia with high astigmatism is difficult to treat surgically. In addition, there are not many suitable options to offer such patients presenting with this condition. The method used at the EYE Hospital Pristina using fresh lenticule implantation by ReLex-SMILE is safe and effective method. Fresh Corneal Implantation is a safe treatment for hyperopia with high astigmatism comparing with refractive IOL implantation (loss of accommodation, endophthalmitis). Its primary objective is to increase visual acuity, accommodation process, patient satisfaction which makes patient to enjoy a happier life. We believe this study will be the future of refractive surgery for treating high hyperopia.

NCT ID: NCT03805425 Active, not recruiting - Hyperopia Clinical Trials

PiXL for Correction of Hyperopia

Start date: December 2016
Phase: N/A
Study type: Interventional

This clinical study aims to investigate the efficacy and safety of PiXL in the refractive correction of low hyperopia.

NCT ID: NCT03610997 Active, not recruiting - Hyperopia Clinical Trials

Photorefractive Keratectomy for Severe Anisometropia and Isoametropia Associated With Amblyopia

Start date: January 1, 2001
Phase: N/A
Study type: Interventional

Photorefractive keratectomy (PRK) with excimer laser has been used successfully to treat myopia, hyperopia, and astigmatism in adults for over 35 years. Children with high refractive errors that go untreated will develop severe amblyopia. PRK can normalize high refractive errors and potentially improve the visual acuity in affected children. The purpose of this study is to investigate whether children with high anisometropia or isoametropia with amblyopia that are nonresponsive to standard therapy and receive PRK develop better longterm visual acuity.

NCT ID: NCT03431571 Active, not recruiting - Hypermetropia Clinical Trials

Use of the VisuMax Femtosecond Laser Lenticule Removal Procedure for the Correction of Hyperopia

V1601CI
Start date: July 5, 2017
Phase: N/A
Study type: Interventional

The correction of farsightedness using ReLEx SMILE for hyperopia is focus of this investigation. The objective is to evaluate the safety and effectiveness.

NCT ID: NCT00950924 Active, not recruiting - Refractive Error Clinical Trials

Optical Defocus to Stimulate Eye Elongation in Hyperopia

ODSEEH
Start date: January 2015
Phase: N/A
Study type: Interventional

Axial hyperopia results when the length of the eye is too short for the eye to properly focus distance objects on the retina while the focusing system is relaxed. Emmetropization is the process by which the eye actively adjusts various components of the eye to gradually improve the focus of the eye. Emmetropization frequently involves either an increase or a decrease in the growth of the eye, particularly during infancy and childhood. Numerous animal studies suggest that if an animal is exposed to retinal images located behind the retina either centrally or peripherally, the eye will grow in the direction of the focused image. If an abnormally short eye has resulted in hyperopia, exposing such an eye to retinal images partially located behind the retina might encourage axial elongation, thus reducing the hyperopia.